Wilex AG (WL6.DE) Restructures, Cuts Jobs
12/5/2012 8:32:58 AM
More...
|
Wilex AG (WL6.DE)'s Kidney Cancer Drug Fails in Late Stage Trial
10/17/2012 8:27:10 AM
More...
|
Prometheus Laboratories Inc. Obtains Exclusive US Commercialization Rights for RENCAREX(R) from Wilex AG; Wilex to Receive $19 Million Upfront
5/2/2011 7:00:06 AM
More...
|
Wilex AG's Redectane(R) Meets Both Endpoints Specificity And Sensitivity With Superiority Over CT In Its Pivotal Phase III Trial
5/19/2010 8:11:03 AM
More...
|
UCB Group (UCBJF.PK) and Wilex AG to Enter into Strategic Alliance to Develop UCB's Preclinical Oncology Portfolio
1/9/2009 6:39:19 AM
More...
|
Wilex AG Closes A EUR 30 Million ($39 Million) Series C Private Equity Round
10/19/2005 5:10:22 PM
More...
|
14th Annual Report: Top 100 Biotechnology Companies
10/19/2005 5:09:32 PM
More...
|
Wilex AG Starts Patient Enrolment In Rencarex Pivotal Phase III Trial In Renal Cell Carcinoma
10/19/2005 5:08:45 PM
More...
|